# FDA recall D-1190-2018

> **Baxter Healthcare Corporation** · Class II · drug recall initiated 2018-09-06.

## Product

0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31

## Reason for recall

cGMP Deviation

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-1190-2018
- **Recalling firm:** Baxter Healthcare Corporation
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-09-06
- **Report date:** 2018-09-26
- **Termination date:** 2020-10-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Deerfield, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1190-2018

## Citation

> AI Analytics. FDA recall D-1190-2018. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/D-1190-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*